Targeting Tau

Treating Alzheimer’s disease and other neurodegenerative disorders by blocking tau pathology

Asceneuron discovers and develops groundbreaking therapeutics for neurodegenerative disorders with high unmet medical needs: orphan tauopathies, Alzheimer’s and Parkinson’s diseases.

Developing oral drugs to improve patient’s lives

We are a passionate team of scientists and drug developers dedicated to improving the lives of patients affected by neurodegenerative diseases, such as Alzheimer’s, Parkinson’s and orphan taupathies.